Your gift is 100% tax deductible.
Chemotherapy for Ewing Sarcoma
Chemotherapy (chemo) is the use of drugs to treat cancer. The drugs are usually given into a vein (IV) or by mouth and can reach and destroy cancer cells throughout the body.
Typically, chemo is the first treatment given (neoadjuvant chemo), followed by surgery and/or radiation therapy. In some people with Ewing sarcoma, chemo can shrink the main tumor, which might make surgery easier or the radiation field smaller. More chemo is often given again after surgery and/or radiation (known as adjuvant chemo) to kill any cancer cells that are left.
Even if the Ewing tumor is localized, the cancer would likely come back in other parts of the body if chemotherapy isn't given. Most people with Ewing sarcoma have very small areas of cancer spread (micrometastases) that can’t be seen on imaging tests. Giving chemo along with surgery and/or radiation helps lower the risk of the cancer coming back.
Chemo is given in cycles, with a period of treatment (often a few days in a row) followed by a rest period to give the body time to recover. Each cycle lasts a couple of weeks.
Which chemo drugs are used to treat Ewing sarcoma?
The drugs most often used to treat Ewing sarcoma include:
- Vincristine
- Doxorubicin
- Cyclophosphamide
- Ifosfamide
- Etoposide
In the United States, the most common chemo regimen is known as VDC/IE. It alternates between 2 combinations of drugs (vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide), given every 2 to 3 weeks.
Most patients get chemo for 8 to 12 weeks before surgery or radiation, and more chemo afterward as well. Usually, about 14 to 17 cycles of chemo are given, which can take up to a year to complete, depending on the schedule.
Some doctors may use slightly different drug combinations. These often include many of the same chemo drugs listed above, although other drugs might be used as well.
Other chemo drugs may be used if Ewing sarcoma comes back after treatment. These include:
- Topotecan
- Cyclophosphamide
- Temozolomide
- Irinotecan
- Docetaxel
- Gemcitabine
Possible side effects of chemo
Chemo drugs affect cells that grow fast. While cancer cells grow fast, other healthy cells in the body do too – for example, blood-forming cells, hair cells, and cells that make up the lining of our gut. Side effects result from damage to fast-growing healthy cells caused by these drugs. The specific side effects of chemo drugs depend on the type, dose, and the length of time they are given.
Common side effects of many chemo drugs include:
- Nausea and vomiting
- Loss of appetite
- Diarrhea or constipation
- Hair loss
- Mouth sores
Chemo can damage the bone marrow, where new blood cells are made. This can lead to low blood cell counts, which can result in:
- Increased chance of infection (from low white blood cells)
- Easy bruising or bleeding (from low blood platelets)
- Fatigue (from low red blood cells)
Most of these side effects tend to go away after treatment is finished. There are often ways to make these side effects less severe. For example, drugs can be given to help prevent or reduce nausea and vomiting or to help get blood counts back to normal levels. Be sure to discuss any questions you have about side effects with the cancer care team. Tell them about any side effects you are having so they can be managed.
Long-term side effects of chemo
Chemotherapy can also have some longer-term side effects. For example, some drugs can increase the risk of later developing another type of cancer (such as leukemia). While this is a serious risk, it is not common, and the small increase in risk must be weighed against the importance of chemotherapy in treating Ewing sarcoma.
Learn more in After Treatment for Ewing Sarcoma.
Side effects of certain chemo drugs
Some chemo drugs can have specific side effects. For example:
Alkylating agents, like cyclophosphamide and ifosfamide, can damage the bladder lining, which can cause blood in urine. This risk can be lowered by giving the drugs with plenty of fluids and with a drug called mesna, which helps protect the bladder.
These drugs can also damage the ovaries or testicles, which could affect fertility (the ability to have children). Talk to your cancer care team about the risks of infertility with treatment and ask if there are options for preserving fertility.
In some people, ifosfamide can cause symptoms like confusion or personality changes (called encephalopathy), which can be treated and usually improves with time.
Doxorubicin (Adriamycin) can damage the heart muscle. This risk goes up with higher doses of the drug, so doctors are careful to watch the heart during treatment and limit the total dose of doxorubicin.
The doctor will order a heart function test (like an echocardiogram) before and during treatment to watch and see if this drug is affecting the heart. A drug called dexrazoxane may be given along with the chemo to help lessen the possible damage.
Vincristine can cause nerve damage (neuropathy). Some people may notice tingling and numbness, particularly in their hands and feet, or constipation. These symptoms often go away or get better once treatment is stopped, but they might last longer in some people.
Etoposide can increase the risk of developing leukemia later on, although this is not common.
The doctors and nurses will watch closely for side effects. Do not hesitate to ask the cancer care team any questions about side effects.
For more information on possible late or long-term side effects of chemo, including infertility and second cancers, see Long-term and Late Effects of Cancer Treatment or Long-term and Late Effects of Childhood Cancer Treatment.
More information about chemotherapy
For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
- Written by
- References
Developed by the P站视频 medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
DuBois SG, Krailo MD, Glade-Bender J, et al. Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2023;41(11):2098-2107.
Leavey PJ, Laack NN, Krailo MD, et al. Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report. J Clin Oncol. 2021;39(36):4029-4038.
Lessnick SL, Grohar PJ, DuBois SG, Hogendoorn PCW, et a. Chapter 27: Ewing Sarcoma. In: Blaney SM, Adamson PC, Helman LJ, eds. Pizzo and Poplack’s Pediatric Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2021.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Bone Cancer. v.1.2026 – September 11, 2025. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf on October 21, 2025.
National Cancer Institute. Ewing Sarcoma Treatment. Accessed at https://www.cancer.gov/types/bone/hp/ewing-treatment-pdq on October 21, 2025.
Setty BA, Gikandi A, DuBois SG. Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents. Paediatr Drugs. 2023;25(4):389-397.
Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol. 2012;30(33):4148-4154.
Last Revised: January 12, 2026
P站视频 medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
P站视频 Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the P站视频.